In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
NCT03296072
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Tooth Erosion
Interventions
DRUG:
0.254% w/w sodium fluoride and 5% KNO3
DRUG:
0.454% w/w stannous fluoride
DRUG:
5% KNO3
Sponsor
GlaxoSmithKline